Clearside Biomedical (Germany) Market Value
| CLM Stock | EUR 0.53 0.20 27.40% |
| Symbol | Clearside |
Clearside Biomedical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Clearside Biomedical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Clearside Biomedical.
| 04/20/2025 |
| 07/19/2025 |
If you would invest 0.00 in Clearside Biomedical on April 20, 2025 and sell it all today you would earn a total of 0.00 from holding Clearside Biomedical or generate 0.0% return on investment in Clearside Biomedical over 90 days. Clearside Biomedical is related to or competes with Apple, Apple, Apple, Apple, Apple, Apple, and Microsoft. More
Clearside Biomedical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Clearside Biomedical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Clearside Biomedical upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 29.29 | |||
| Value At Risk | (5.33) | |||
| Potential Upside | 2.99 |
Clearside Biomedical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Clearside Biomedical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Clearside Biomedical's standard deviation. In reality, there are many statistical measures that can use Clearside Biomedical historical prices to predict the future Clearside Biomedical's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.28) | |||
| Total Risk Alpha | (0.96) | |||
| Treynor Ratio | 7.54 |
Clearside Biomedical Backtested Returns
Clearside Biomedical secures Sharpe Ratio (or Efficiency) of -0.0706, which signifies that the company had a -0.0706 % return per unit of standard deviation over the last 3 months. Clearside Biomedical exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Clearside Biomedical's mean deviation of 1.95, and Risk Adjusted Performance of (0.05) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.0378, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Clearside Biomedical are expected to decrease at a much lower rate. During the bear market, Clearside Biomedical is likely to outperform the market. At this point, Clearside Biomedical has a negative expected return of -0.34%. Please make sure to confirm Clearside Biomedical's coefficient of variation, total risk alpha, skewness, as well as the relationship between the information ratio and maximum drawdown , to decide if Clearside Biomedical performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.02 |
Very weak reverse predictability
Clearside Biomedical has very weak reverse predictability. Overlapping area represents the amount of predictability between Clearside Biomedical time series from 20th of April 2025 to 4th of June 2025 and 4th of June 2025 to 19th of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Clearside Biomedical price movement. The serial correlation of -0.02 indicates that only 2.0% of current Clearside Biomedical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.02 | |
| Spearman Rank Test | 0.09 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Clearside Biomedical lagged returns against current returns
Autocorrelation, which is Clearside Biomedical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Clearside Biomedical's stock expected returns. We can calculate the autocorrelation of Clearside Biomedical returns to help us make a trade decision. For example, suppose you find that Clearside Biomedical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Clearside Biomedical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Clearside Biomedical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Clearside Biomedical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Clearside Biomedical stock over time.
Current vs Lagged Prices |
| Timeline |
Clearside Biomedical Lagged Returns
When evaluating Clearside Biomedical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Clearside Biomedical stock have on its future price. Clearside Biomedical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Clearside Biomedical autocorrelation shows the relationship between Clearside Biomedical stock current value and its past values and can show if there is a momentum factor associated with investing in Clearside Biomedical.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Clearside Stock Analysis
When running Clearside Biomedical's price analysis, check to measure Clearside Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearside Biomedical is operating at the current time. Most of Clearside Biomedical's value examination focuses on studying past and present price action to predict the probability of Clearside Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearside Biomedical's price. Additionally, you may evaluate how the addition of Clearside Biomedical to your portfolios can decrease your overall portfolio volatility.